Table 4. Cytotoxic Activity of 2 and 3 against Human Cancer Cells and Normal Cells (IC50, μM) and Their Selective Indexesa.
IC50 (μM) |
||||
---|---|---|---|---|
compounds | HL-60 | A549 | MRC-5 | SIc |
2a | 0.36 ± 0.023 | 0.38 ± 0.003 | 0.68 ± 0.013 | 1.79 |
2b | 0.27 ± 0.017 | 0.73 ± 0.015 | 0.60 ± 0.008 | 0.82 |
2c | 0.23 ± 0.013 | 0.75 ± 0.006 | 0.37 ± 0.019 | 0.49 |
3a | 2.59 ± 0.195 | 0.88 ± 0.023 | 0.87 ± 0.063 | 0.99 |
3b | 0.67 ± 0.038 | 0.33 ± 0.010 | 0.54 ± 0.009 | 1.64 |
3c | 2.20 ± 0.070 | 0.66 ± 0.016 | 0.66 ± 0.041 | 1.00 |
SN-38b | 0.056 ± 0.002 | 0.052 ± 0.003 | 0.092 ± 0.001 | 1.77 |
The concentration of the compound needed to reduce cell viability by 50% (IC50) was determined using the WST-8 assay. IC50 values are expressed as the mean ± SD of triplicate experiments.
SN-38 was used as a positive control.
The SI is defined as the IC50 value against normal MRC-5 cells divided by the IC50 value against A549 cells.